Just online. Very happy to participate to this important paper for young women with pregnancy and oncogen driven advanced NSLCC. Help us to better manage this condition. @NarjustFlorezMD and #MImbimbo 🙏
cadranel jacques
@CadranelJ
Chest Department, Thoracic Oncology Center/Rare Pulmonary Diseases - Hôpital Tenon APHP-Sorbonne Université. "Patients first and foremost". Tweets are my own.
67 Following 1.6K Followers 8.7K Posts
Latest posts 5
Happy to share the results of our psychosocial long term burden evaluation of French patients living with ALK disease. 82% of psychological difficulties and many others. Lower perception by oncologists. @AlkRos1France #rcorre #bmennecier
Congrats to the NEJ group for doing the job. Could we reduced AE and therefore post-op mortality in LC-IPF? The response is maybe with pirfenidone in highly selected population, CVF >95%. Would be addressed in more severe although operable patients? @RespiFIL @IFCTlung
At ESMO feasibility study on DNA/RNA direct analysis on bronchoscopic of patients with suspected NSCLC. BiLiBro NCT06228508 prospective study ongoing results @FalletVincent @APHP @HopitalTenon @Sorbonne_Univ_
At ESMO 2024, #Lana Élu and @AnthonyCanellas reported the largest of T-Dxd related ILD in 600 non Asian pts. 11%, delay of onset 83 dys, risk factors previous known(unknown) ILA, liver disease. Mainly grade 1-2, mostly OP pattern, 9% DAD. 9% mortality, %80 in DAD.